WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'4401 Infant (under 12 months) mortality rate: 242
GDP / capita (US$): 6'9161 Child (under 5 years) mortality rate: 302

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 100'096  98'394  96'707  95'053  93'444  77'652  61'949  47'398 
Births 2'425  2'404  2'383  2'362  2'344  2'301  2'043  1'737 
Surviving infants 2'375  2'354  2'332  2'311  2'293  2'236  1'969  1'634 
Pop. less than 5 years 11'521  11'334  11'165  11'097  11'180  10'682  9'450  7'678 
Pop. less than 15 years 33'821  33'593  33'334  33'112  32'970  29'904  25'359  20'434 
Female 15-49 years 25'815  25'337  24'873  24'402  23'909  19'558  15'026  11'009 

Number of reported case

(Click for retrospective incidence data for Philippines (the))
Diphtheria 107  88  921  1'910 
Japanese encephalitis 69  24  181 
Measles 58'848  2'920  1'536  6'538  6'368  7'120  42'938  26'765 
Mumps
Pertussis 23  62  23  4'135  19'844 
Polio* 85  432 
Rubella 264  254  100  926 
Rubella (CRS)
Tetanus (neonatal) 92  77  131  166  126  281  291  1'506 
Tetanus (total)** 839  1'069  1'537  1'140  1'135  2'286  3'080 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Philippines (the))
Vaccine year result method % card seen                                                
BCG 2012  95  DHS   58  87  91  88  84  83  81  96  74 
DTP1 2012  94  DHS   58  86  98  90  85  81  81 
DTP3 2012  86  DHS   58  79  94  86  80  79  79  88  47 
DTP4         
IPV1         
HepB_BD          54  44  35  40  37 
HepB3 2012  78  DHS   58  79  94  70  76  77 
Hib3          79  94  23  14 
JapEnc         
MCV1          88  90  85  79  80  80  85 
MCV2          64  53  38  28  10 
PCV1          42 
PCV3          35 
Pol3 2012  85  DHS   58  84  88  86  80  78  75  88  50 
Rota1          21  95  46 
Rota_last          12  97  19 
Rubella1          64 
TT2plus 2003  37  DHS   39  36  28  28  38  28  58  47 
PAB         
VAD1          85  91  94  74 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Philippines (the))
BCG 87  91  88  84  83  92  96  56 
DTP1 86  98  90  85  81  92  96  72 
DTP3 79  94  86  80  79  78  88  47 
HepB3 79  94  70  76  77 
HepB_BD 54  44  35  40  37 
Hib3 79  94  23  14 
MCV1 88  90  85  79  80  78  85 
MCV2 64  53  38  28  10 
PAB 87  80  76  76  75  55  57 
PCV3
Pol3 84  88  86  80  78  74  88  50 
Rota_last 28 

Number of districts in the country 225  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 34
From 80 to 89% 29
From 50 to 79% 30
Less than 50% 4
Proportion of districts
not reporting DTP3 coverage
3
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 1st contact; +6 months; No
HepB birth; Yes
IPV 14 weeks; No
Influenza_Adult Yes elderly
MMR 12 months; Yes
MR Grade 7 No
Measles 9 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6-15, 32 weeks; No
TT Yes pregnant women
Td Grade 7; No
VitaminA 6, 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  Yes  No  No  No  Yes 
What years does the MYP cover? number     2012-2016        2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 191  218  110  217  217  90  90 

System performance

Total Nº districts in country number 225  218  217  217  217  179  217 
Nº districts with DTP3 coverage >=80% number 142  115  110  103  81  128  146 
% of districts with DTP3 coverage >=80% From 0 to 100% 63  53  51  47  37  72  67 
Nº districts with measles (MCV1) coverage >=95% number 18  40  32  36  28  48  62 
% of districts with MCV1 coverage >=95% From 0 to 100% 18  15  17  13  27  29 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100      171  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.